Labeyrie Fine Foods has sold its frozen business to Ajinomoto
Lincoln International (“Lincoln”), a leading global mid-market investment bank, is pleased to announce that Labeyrie Fine Foods, a portfolio company of PAI Partners and Lur Berri, has sold its frozen business, Labeyrie Traiteur Surgelés, to the Japan-based group Ajinomoto.
With over €50 million of sales in 2016, Labeyrie Traiteur Surgelés (or “LTS” or the “Company”) is a leading manufacturer of frozen products such as appetizers, desserts and tourtes. Within its niche market, LTS benefits from an extensive offering of quality products through complementary premium brands (Lenôtre, Labeyrie and Blini) and private labels. The company enjoys a large base of customers comprised of French leading retailers.
The Company operates two production sites in France in Le Neubourg and Castelsarrasin benefiting from long-standing technical know-how. The two sites enjoy sufficient available production capacity to further support growth and to enlarge product offerings.
Capitalizing in the coming years on a leading position in several niche markets, as well as on a diversified portfolio of premium brands, LTS has identified numerous development opportunities such as the launch of new products and the diversification into the defrost sweets segment. With the support of Ajinomoto, LTS is looking to pursue industrial development of the sites and to continue to expand its client base and to expand its international presence on the premium segment. Meanwhile, Ajinomoto will capitalize on this acquisition to further strengthen its consumer foods business in Europe.
Lincoln acted as the exclusive sell-side advisor to Labeyrie Fine Foods throughout the sale process.
Meet our Senior Team
I build strong relationships through active and continuous communication.
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical